معرفی
Dr. Annaliese Dillon is a Research Fellow in Medicinal Chemistry at Monash University, affiliated with the Department of Chemistry within the Faculty of Science. She is actively contributing to antimalarial drug discovery through her role as a Chief Investigator in a major research project funded through 2027.
Her research focuses on synthetic organic chemistry, particularly the development of novel domino reactions and cyclization strategies for constructing complex heterocyclic frameworks. These methods have applications in medicinal chemistry and drug design, especially in the context of antimalarial agents. Her work bridges synthetic innovation with biological relevance.
The two most recent publications highlight her expertise in constructing polyfused chalcogenophenes and highly substituted indenes using efficient, acid-promoted cyclizations. These studies reflect a consistent theme in methodology development for bioactive molecule synthesis.
- No scientific awards currently listed.
Dr. Dillon has not publicly listed any graduate students or advisees. However, she is actively involved in externally funded research, notably the project Discovery of New Antimalarials with a Novel Mechanism of Action and Irresistible Target, indicating grant leadership and collaborative research capacity. She collaborates with prominent researchers in parasitology, drug metabolism, and pharmaceutical sciences.
While specific lab or team affiliations are not detailed, her work appears integrated within Monash’s broader drug discovery and medicinal chemistry research ecosystem, likely linked to the Monash Institute of Pharmaceutical Sciences (MIPS).
